Summary
Our vision is to preserve Improve the quality of life by reducing silent stroke impact. We will develop, manufacture, and introduce the first easy-to-use device for alerting stroke for high-risk populations. The first market is hospital use during sedation, with the end-stage market being home telemonitoring. The company has a clear patentable product, a large growing market, and an expert and experienced team. StrokeAlert's intellectual property is an alerting system via continuous monitoring of hemodynamic parameters (patent submitted). StrokeAlert's impact will be reducing morbidity and mortality from stroke. We shall compare patients' neurological outcomes with and without StrokeAlert.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101071850 |
| Start date: | 01-07-2022 |
| End date: | 30-06-2023 |
| Total budget - Public funding: | - 75 000,00 Euro |
Cordis data
Original description
Our vision is to preserve Improve the quality of life by reducing silent stroke impact. We will develop, manufacture, and introduce the first easy-to-use device for alerting stroke for high-risk populations. The first market is hospital use during sedation, with the end-stage market being home telemonitoring. The company has a clear patentable product, a large growing market, and an expert and experienced team. StrokeAlert's intellectual property is an alerting system via continuous monitoring of hemodynamic parameters (patent submitted). StrokeAlert's impact will be reducing morbidity and mortality from stroke. We shall compare patients' neurological outcomes with and without StrokeAlert.Status
SIGNEDCall topic
HORIZON-EIE-2021-SCALEUP-01-03Update Date
09-02-2023
Geographical location(s)
